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Abstract The tegumental changes in adult Opisthorchis
viverrini induced by tribendimidine were analyzed by
scanning electron microscopy (SEM). We exposed
O. viverrini to tribendimidine at a concentration of 10 μg/
ml for 4 h. In addition, hamsters were treated with a single
400 mg/kg oral dose of tribendimidine and flukes were
recovered from the bile ducts 24, 48, 72, and 96 h post-
treatment. SEM analysis of the flukes incubated in vitro
showed only mild damage of the tegument. Twenty-four
hours post-treatment of hamsters, extensive disruption such
as sloughing, furrowing, or blebbing of the tegument was
evident, which did not increase in severity 48–72 h post-
treatment. Ninety-six hours after tribendimidine adminis-
tration, the majority of flukes had been expelled. A single
400 mg/kg oral dose of tribendimidine administered to
O. viverrini-infected hamsters yielded a worm burden
reduction of 63.0%. In conclusion, our experiments confirm
that tribendimidine possesses interesting trematocidal prop-
erties, which warrant additional investigations and provide
further data for subsequent clinical trials.
Introduction
Opisthorchis viverrini, a liver fluke belonging to the food-
borne trematodes, is the causative agent of opisthorchiasis. At
present, an estimated 67.3 million people are at risk and 9
million are infected with the highest prevalence found in
Cambodia, Lao People’s Democratic Republic, Thailand, and
Viet Nam. The most serious complication of opisthorchiasis is
cholangiocarcinoma, the bile duct cancer (Haswell-Elkins and
Levri 2003; Sripa 2003; Keiser and Utzinger 2007b). Since
the early 1980s, when the good safety and therapeutic profile
of praziquantel against opisthorchiasis had been established,
treatment and control of opisthorchiasis relies on this drug
(Keiser and Utzinger 2007b). Although treatment failures
have not yet been reported for praziquantel in O. viverrini-
infected patients, the search for alternative trematocidal
drugs is warranted. A promising strategy to develop novel
drugs for neglected tropical diseases, in this case food-
borne trematodiasis, is based on label extensions of existing
drugs (Nwaka and Hudson 2006). Hence, evaluating the
trematocidal potential of drugs that are already on the market
for related diseases is a key approach for our own drug
discovery and development portfolio at the Swiss Tropical
Institute (Keiser and Utzinger 2007a).
Tribendimidine is a derivative of amidantel, synthesized
and developed in China (Ren et al. 1987). Laboratory and
clinical investigations demonstrated that this drug is safe
and has a broad spectrum of activity against nematodes that
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are of considerable public health significance (e.g., Ascaris
lumbricoides, Enterobius vermicularis, and the hook-
worms) (Xiao et al. 2005). New research has shown that
tribendimidine is also active against Strongyloides ratti, in
particular the adult stages (Keiser et al. 2008). Importantly,
in recent laboratory investigations we could extend activity
from nematodes to trematodes. For example, worm burden
reductions of 100% were achieved with a single 125-mg/kg
oral dose of tribendimidine against the intestinal trematode
Echinostoma caproni harbored in mice (Keiser et al.
2006c). High worm burden reductions were also achieved
with single oral doses of tribendimidine against Clonorchis
sinensis in the rat and O. viverrini in the hamster (Keiser et
al. 2006a).
The aim of this study was to further clarify the
opisthorchicidal properties of tribendimidine. We first
evaluate the therapeutic efficacy of tribendimidine after a
single oral dose administered to hamsters infected with
adult O. viverrini. Next, we assessed tegumental alterations
in adult O. viverrini recovered from treated hamsters using
a scanning electron microscope (SEM). Finally, we inves-
tigated drug-induced tegumental alterations of O. viverrini
after in vitro exposure to tribendimidine.
Materials and methods
Tribendimidine
Tribendimidine was obtained from the Department of
Pharmaceutics, National Institute of Parasitic Diseases,
Chinese Center for Disease Control and Prevention (Shanghai,
China). The drug was prepared in homogenous suspensions
in 7% Tween-80 and 3% ethanol before oral administration.
For the in vitro studies, a 10-mg/ml stock solution of
tribendimidine was prepared in 60% DMSO (v/v).
Ethical clearance and O. viverrini–hamster model
All animal studies presented here were approved by the
local government of Basel, according to Swiss national
regulations.
Metacercariae of O. viverrini were obtained from
cyprinoid fish caught in Khon Kaen province, Thailand,
as described previously (Keiser et al. 2006a).
Fifteen female Syrian Golden hamsters, aged 3 weeks
with a weight of ∼100 g, were purchased from Charles
River (Sulzfeld, Germany). Animals were kept in groups of
four in environmentally controlled conditions (temperature
∼25°C, humidity ∼70%, 12-h light and 12-h dark cycle)
and acclimatized for 1 week. Hamsters had free access to
water and rodent diet. The hamsters were each infected
intragastrically with 45 O. viverrini metacercariae.
In vivo efficacy
Four weeks post-infection, five hamsters were treated orally with
a single 400-mg/kg dose of tribendimidine. Six hamsters were
left untreated and served as controls. Hamsters were killed and
dissected 2 weeks post-treatment. O. viverrini were removed
from the liver, gall bladder, and bile ducts and counted. We
used the Kruskal–Wallis test (KW) to test for statistical
significance of the median worm counts between the treatment
and control group. Statistical significance was considered at a
level of 5%. We used version 2.4.5 of Statsdirect (Statsdirect
Ltd; Cheshire, UK) for statistical analysis.
In vitro SEM observations
Opisthorchis viverrini obtained from untreated control
animals were rinsed in warm 0.9% (w/v) NaCl and six
flukes were incubated in 2-ml minimal essential medium
(MEM) (Gibco), supplemented with antibiotics (50 μg/ml
streptomycin plus 50 U/ml penicillin) (Gibco). O. viverrini
were incubated in a medium containing 10 μg/ml of
tribendimidine. Controls were prepared by incubating
flukes in MEM supplemented with antibiotics. Cultures
were kept at 37°C in an atmosphere of 5% CO2 and
observed after exposure for 4 h under a dissecting
microscope. Subsequently, all flukes were collected and
processed for SEM as described below.
In vivo SEM observations
Four hamsters were treated intragastrically with tribendimidine
at a single 400-mg/kg dose 5 weeks post-infection. Twenty-
four, 48, 72, and 96 h post-treatment, one hamster each was
euthanized by CO2, and flukes were collected from the bile
ducts. O. viverrini from untreated hamsters served as control.
The flukes were washed in saline solution and fixed with
2.5% glutaraldehyde in a phosphate-buffered saline (PBS)
solution for 24 h at room temperature. After rinsing with
PBS, the flukes were washed with distilled water, dehydrated,
and critically point-dried (Bomar SPC-900; Tacoma, WA,
USA). After sputter coating with gold of 20 nm (Baltec Med
020; Tucson, AZ, USA), the flukes were mounted on
aluminum stubs and observed in a high-resolution SEM
(Philips XL30 ESEM; Eindhofen, the Netherlands) at an
accelerating voltage of 5 kV.
Results
In vivo drug efficacy
The effect of tribendimidine on adult O. viverrini harbored
in hamsters, as assessed by worm burden reduction, is
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summarized in Table 1. The mean worm burden observed
in untreated control hamsters was 10.8 worms (standard
deviation [SD]=3.1 worms). After a single 400-mg/kg oral
dose of tribendimidine, a mean worm burden of 4.0 worms
(SD=4.5 worms) was found, which translated to a worm
burden reduction of 63.0% (KW=3.76, P=0.052).
SEM observations of control O. viverrini
The tegument of adult O. viverrini recovered from untreated
hamsters and also incubated in vitro appeared normal.
Figure 1 depicts the dorsal surface of an adult O. viverrini,
and Fig. 2 shows the oral sucker of the same specimen.
In vitro SEM observations
Opisthorchis viverrini exposed to tribendimidine at a
concentration of 10 μg/ml contracted immediately. Within
4 h of incubation in a culture medium containing 10 μg/ml
tribendimidine all O. viverrini had died. SEM analysis from
these flukes revealed an intact tegument (Fig. 3). The only
difference we observed to untreated O. viverrini was a
slightly reduced opening of the oral sucker (Fig. 4),
blebbing on the tegumental surface (Fig. 3), and blebbing
and swelling near the oral sucker (Fig. 4).
In vivo SEM observations
Twenty-four hours after administration of a single 400-mg/kg
dose of tribendimidine to O. viverrini-infected hamsters, 10
flukes were recovered from the bile ducts. These flukes
showed normal mobility. SEM observations of the flukes,
however, revealed substantial tegumental damage both on
the ventral and dorsal portions of the flukes as well as on the
anterior and posterior regions of the trematodes. There was a
reduced opening of the oral sucker (Fig. 5). Extensive
sloughing was detected on the entire ventral and dorsal
surfaces of most flukes examined (Figs. 6, 7 and 8).
Numerous blebs were visible near the ventral sucker and
the ventral and dorsal surfaces (Figs. 6, 7 and 8). Severe
tegumental damage was also seen in the tail regions of the
trematodes (Fig. 8).
Forty-eight hours post-treatment, nine O. viverrini could
be recovered from the one hamster killed at this time point
Fig. 1 Opisthorchis viverrini
obtained from an untreated con-
trol hamster
Fig. 2 Oral sucker (OS) and
papillae (P) of a control
O. viverrini
Fig. 3 SEM of adult O. viverrini
after exposure to 10 μg/ml tri-
bendimidine in vitro. Ventral
tegument with ventral sucker
(VS) of O. viverrini. Light bleb-
bing (B) visible
Fig. 4 SEM of adult O. viverrini
after exposure to 10 μg/ml tri-
bendimidine in vitro. Reduced
opening, swelling (SW) and
blebbing (B) of oral sucker (OS)












Control – 6 0 10.8 (3.1) – – –
Tribendimidine 400 5 0 4.0 (4.5) 63.0 3.76 0.052
SD Standard deviation
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after tribendimidine administration. The flukes showed
reduced mobility. SEM observations of these flukes showed
similar tegumental disruption as during the previous time
point, characterized by extensive sloughing of the tegument
(no picture shown). Moreover, several trematodes showed a
complete closure of their oral sucker (Fig. 9). In one
specimen, extensive furrowing was also observed on the
dorsal surface (Fig. 10).
Seventy-two hours after tribendimidine administration, we
were able to extract 10 O. viverrini from the bile duct of the
one hamster designated at this time point. All
O. viverrini were alive, but showed reduced mobility.
Tegumental damage was pronounced, and prominent find-
ings included the sloughing of the tegumental surfaces
(Figs. 11 and 12). Actually, the whole flukes were covered
in blebs (Figs. 11 and 12).
Fig. 9 SEM of adult O. viverrini
48 h post-treatment with a
single 400-mg/kg oral dose of
tribendimidine. Closure of
the oral sucker (OS) and
blebbing (B)
Fig. 10 SEM of adult
O. viverrini 48 h post-treatment
with a single 400-mg/kg oral
dose of tribendimidine. Blebbing
(B) and furrowing (F) on the
dorsal surface
Fig. 11 SEM of adult
O. viverrini 72 h post-treatment
with a single 400-mg/kg oral
dose of tribendimidine. Exten-
sive sloughing (S) and blebbing
(B) near the ventral sucker (VS)
Fig. 12 SEM of adult
O. viverrini 72 h post-treatment
with a single 400 mg/kg oral
dose of tribendimidine. Blebbing
(B) and sloughing (S) on the
dorsal surface
Fig. 5 SEM of adult O. viverrini
24 h post-treatment with a
single 400-mg/kg oral dose of
tribendimidine. Closure of the
oral sucker (OS)
Fig. 6 SEM of adult O. viverrini
24 h post-treatment with a
single 400-mg/kg oral dose of
tribendimidine. Sloughing (S)
and blebbing (B) near the ventral
sucker (vs)
Fig. 7 SEM of adult O. viverrini
24 h post-treatment with a
single 400-mg/kg oral dose of
tribendimidine. Sloughing (S)
and blebbing (B) near the ventral
sucker (vs)
Fig. 8 SEM of adult O. viverrini
24 h post-treatment with a
single 400-mg/kg oral dose of
tribendimidine. Blebbing (B) and
sloughing (S) on the tail region
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Ninety-six hours after treatment, the majority of
O. viverrini had been expelled and only two O. viverrini
could be obtained from the bile duct of the one treated
hamster that was killed at this time point. One of these
flukes was dead. In view of only one specimen alive at this
time point post-treatment, no SEM analysis was carried out.
Discussion
To our knowledge, this is the first temporal examination of
tegumental alterations on the surface of O. viverrini
recovered from hamsters following administration of a
single 400-mg/kg oral dose of tribendimidine, and after in
vitro exposure of O. viverrini to a medium containing
10 μg/ml tribendimidine. We employed SEM as with our
preceding work focusing on different food-borne trema-
todes and investigating the effect of the artemisinins,
synthetic trioxolanes, and tribendimidine (Keiser et al.
2006c; Keiser and Morson 2008).
As discovery and development of drugs against opis-
thorchiasis in particular, and food-borne trematodiasis in
general, has been sparse in the past decades, only few
studies have elucidated the effect of drugs on the tegument
of O. viverrini and other food-borne trematodes. Blebbing,
swelling, and sloughing has been observed in O. viverrini
that had been exposed to the current drug of choice, i.e.,
praziquantel, both in vitro and in vivo (Becker et al. 1981;
Mehlhorn et al. 1983; Sirisinha et al. 1984; Apinhasmit and
Sobhon 1996). In addition, sloughing and tegumental
lesions were documented in O. viverrini specimen follow-
ing multiple doses of the experimental drug amoscanate
(Sobhon et al. 1986). Severe tegumental disruption as
sloughing, furrowing, and blebbing was also observed in
our study after administration of tribendimidine to
O. viverrini-infected hamsters. These tegumental alterations
were already evident 24 h post-treatment.
Interestingly, tegumental changes did not increase
further in severity. An important finding was a reduced
opening of the oral sucker of O. viverrini at 24 h and a
complete closing at 48 h post-treatment. This finding
corroborates with a recent report that elucidated the damage
on the tegument of the intestinal fluke E. caproni after
tribendimidine administration to infected mice (Keiser et al.
2006c). However, in contrast to the tegument of E. caproni,
where mainly the ventral portion and the apical cone region
of the worms were affected after administration of tri-
bendimidine, no clear dorsal–ventral and anterior–posterior
difference in tegument disruption was evident when
O. viverrini were examined by SEM. Furthermore, while
tribendimidine showed a rapid onset of action onE. caproni—
the majority of E. caproni had been expelled 8 h post-
treatment with tribendimidine (Keiser et al. 2006c)—
O. viverrini were still alive 72 h (and one even at 96 h)
post-treatment. Differences in the susceptibility between
these two trematode species, the location of the parasite in
the host, and the different rodent models used (mouse in the
case of E. caproni and hamster in O. viverrini) might explain
these differences.
A quick drug action was also observed when O. viverrini
were incubated in a cultivation medium containing triben-
dimidine. The differences between the fast drug action on
O. viverrini in vitro and the slower action in vivo might be
explained by the extensive biotransformation of the drug. In
fact, it has been demonstrated that tribendimidine is rapidly
metabolized to p-(1-dimethlyamino ethylimino) aniline.
Interestingly, in this study we observed a somewhat lower
worm burden reduction (63.0%) after a single 400-mg/kg
oral dose of tribendimidine was administered to O. viverrini-
infected hamsters when compared to our previous study,
where we found a worm burden reduction of 95.7% at the
same single dose of tribendimidine. This finding might be
explained by inter-individual differences in drug absorption,
gender (female vs. male hamsters, which had been used in
the previous study) and higher infection intensity (mean
worm burden of 10.8 worms per hamster) in this study, when
compared to our previous investigation (mean worm burden:
5.8 worms per hamster). Further studies are necessary to
elucidate the relationship between infection intensities and
the opisthorchicidal effect of tribendimidine and other
potential trematocidal drugs.
In conclusion, our study confirms previous results that
tribendimidine displays interesting trematocidal activity in
vitro and in vivo (Keiser et al. 2006b) and that the tegument
of trematodes is a potential drug target of this anthel-
minthic. Further studies should also assess the damage to
internal tissues and organs by means of transmission
electron microscopy. In addition, the efficacy, tegumental
alterations, and damage to internal tissues and organs of
immature flukes due to tribendimidine administration
remain to be investigated.
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